NYSE:ATNM

Actinium Pharmaceuticals Stock News

Healthcare > Biotechnology

Buy ATNM

*Your capital is at risk

$0.84

-0.0001 (-0.0119%)

At Close: Jul 31, 2026

William Blair Sticks to Its Hold Rating for FibroGen (FGEN)

06:40pm, Friday, 10'th Jan 2020

William Blair analyst Andy Hsieh reiterated a Hold rating on FibroGen (FGEN – Research Report) on January 6. The company’s

Actinium Pharmaceuticals, Inc. to Present at 2020 Biotech Showcase™

12:03pm, Tuesday, 07'th Jan 2020

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium") announced today that Sandesh Seth, Actinium's Chairman and CEO, will present at the 2020 Biotech Showcase™ being held on January 13-

Is Actinium Pharmaceuticals (ATNM) Outperforming Other Medical Stocks This Year?

12:00am, Friday, 03'rd Jan 2020

Tilray (TLRY) in Focus: Stock Moves 9% Higher

12:00am, Thursday, 02'nd Jan 2020

Actinium Pharmaceuticals (ATNM) Investor Presentation - Slideshow

12:00am, Wednesday, 11'th Dec 2019

Actinium Pharmaceuticals Highlights 86% Response Rate and 71% MRD Negative Rate in Actimab-A CLAG-M Combination Trial in Patients with Relapsed or Refractory AML at ASH 2019 Annual Meeting

12:00am, Monday, 09'th Dec 2019

The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling

12:00am, Saturday, 07'th Dec 2019

The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More

12:00am, Sunday, 01'st Dec 2019

Actinium Pharmaceuticals shares are trading lower. Not seeing any news to justify the price action.

12:00am, Monday, 18'th Nov 2019

Sio Capital Management, LLC Buys Johnson & Johnson, Allergan PLC, Pfizer Inc, Sells ...

12:00am, Friday, 15'th Nov 2019

Actinium Pharmaceuticals to Present at the —5th Annual BIO-Europe® —…–9 International ...

12:00am, Thursday, 07'th Nov 2019

Actinium Pharmaceuticals To Present New Clinical Findings From SIERRA Trial Supporting The Iomab-ACT Program For Targeted Lymphodepletion For CAR-T And Adoptive Cell Therapies At ASH 2019 Dec. 7-10

12:00am, Wednesday, 06'th Nov 2019

Actinium Pharmaceuticals shares are trading higher. Not seeing any news to justify the price action.

12:00am, Thursday, 31'st Oct 2019

46 Biggest Movers From Yesterday

12:00am, Tuesday, 29'th Oct 2019

Mid-Afternoon Market Update: Crude Oil Down Over 1%; Liberty Property Trust Shares Spike Higher

12:00am, Monday, 28'th Oct 2019

Actinium Pharmaceuticals Stock News

William Blair Sticks to Its Hold Rating for FibroGen (FGEN)

Actinium Pharmaceuticals, Inc. to Present at 2020 Biotech Showcase™

Is Actinium Pharmaceuticals (ATNM) Outperforming Other Medical Stocks This Year?

Tilray (TLRY) in Focus: Stock Moves 9% Higher

Actinium Pharmaceuticals (ATNM) Investor Presentation - Slideshow

Actinium Pharmaceuticals Highlights 86% Response Rate and 71% MRD Negative Rate in Actimab-A CLAG-M Combination Trial in Patients with Relapsed or Refractory AML at ASH 2019 Annual Meeting

The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling

The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More

Actinium Pharmaceuticals shares are trading lower. Not seeing any news to justify the price action.

Sio Capital Management, LLC Buys Johnson & Johnson, Allergan PLC, Pfizer Inc, Sells ...

Actinium Pharmaceuticals to Present at the —5th Annual BIO-Europe® —…–9 International ...

Actinium Pharmaceuticals To Present New Clinical Findings From SIERRA Trial Supporting The Iomab-ACT Program For Targeted Lymphodepletion For CAR-T And Adoptive Cell Therapies At ASH 2019 Dec. 7-10

Actinium Pharmaceuticals shares are trading higher. Not seeing any news to justify the price action.

46 Biggest Movers From Yesterday

Mid-Afternoon Market Update: Crude Oil Down Over 1%; Liberty Property Trust Shares Spike Higher

Top Fintech Company